Breaking News

STADA Licenses Transdermal Patch from 3M DDS

November 20, 2013

To deliver opioid pain medication fentanyl

STADA Arzneimittel AG has licensed 3M Drug Delivery Systems’ transdermal patch technology for the transdermal delivery of the opioid pain medication fentanyl. Terms of the agreement were not disclosed. 
The 3M Patent (EP 2158905) was granted on March 20, 2013 and enables the transdermal drug delivery of a therapeutically effective amount of fentanyl across the skin of a patient. The matrix device incorporates fentanyl into an adhesive matrix made of a copolymer containing alkyl acrylate and other monomers.
blog comments powered by Disqus
  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • Platinum Press Facility Tour

    Platinum Press Facility Tour

    Kristin Brooks, Contract Pharma||March 23, 2016
    Opens doors to new, 47,000-sq.-ft. packaging facility in Oakland, NJ

  • Biopharma Packaging Equipment Close-up

    Biopharma Packaging Equipment Close-up

    Kristin Brooks, Contract Pharma||March 7, 2016
    Sieghard Schuchmann of OPTIMA discusses biopharma trends impacting packaging equipment, and the latest capabilities